Olink Holding Q3 EPS $(0.01) Beats $(0.08) Estimate, Sales $44.15M Beat $43.24M Estimate
$OLK
Biotechnology: Laboratory Analytical Instruments
Industrials
Olink Holding (NASDAQ:OLK) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.08) by 87.5 percent. This is unchanged from the same period last year. The company reported quarterly sales of $44.15 million which beat the analyst consensus estimate of $43.24 million by 2.12 percent. This is a 38.97 percent increase over sales of $31.77 million the same period last year.